FZAGX
Price
$35.00
Change
+$0.18 (+0.52%)
Updated
May 8 closing price
Net Assets
1.79B
VIVIX
Price
$65.64
Change
+$0.25 (+0.38%)
Updated
May 8 closing price
Net Assets
183.65B
Ad is loading...

FZAGX vs VIVIX

Header iconFZAGX vs VIVIX Comparison
Open Charts FZAGX vs VIVIXBanner chart's image
Fidelity Advisor Equity Income Z
Price$35.00
Change+$0.18 (+0.52%)
VolumeN/A
Net Assets1.79B
Vanguard Value Index I
Price$65.64
Change+$0.25 (+0.38%)
VolumeN/A
Net Assets183.65B
FZAGX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FZAGX vs. VIVIX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZAGX is a Buy and VIVIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. FZAGX (1.79B). FZAGX pays higher dividends than VIVIX: FZAGX (2.48) vs VIVIX (2.35). FZAGX was incepted earlier than VIVIX: FZAGX (12 years) vs VIVIX (27 years). FZAGX (0.47) is less costly to investors than VIVIX (0.04). FZAGX is a more actively managed with annual turnover of: 50.00 vs. VIVIX (9.00). FZAGX has a lower initial minimum investment than VIVIX: FZAGX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 5.12 vs. FZAGX (1.18). VIVIX return over 5 years is better than : 72.19 vs. FZAGX (54.93).
FZAGXVIVIXFZAGX / VIVIX
Total Expense Ratio0.470.041,175%
Annual Report Gross Expense Ratio0.470.041,175%
Fund Existence12 years27 years-
Gain YTD0.071-0.942-8%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.79B184B1%
Annual Yield % from dividends2.482.35105%
Returns for 1 year1.185.1223%
Returns for 3 years14.2520.6669%
Returns for 5 years54.9372.1976%
Returns for 10 years11.2096.2112%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORIC5.320.62
+13.19%
Oric Pharmaceuticals
PDSB1.220.06
+5.17%
PDS Biotechnology Corp
UBS31.080.20
+0.65%
UBS Group AG
DNOW14.54-0.12
-0.82%
DNOW
RYAN70.13-0.80
-1.13%
Ryan Specialty Holdings